Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929. - Karim NA; Miao J; Reckamp KL; Gay CM; Byers LA; Zhao YQ; Redman MW; Carrizosa DR; Wang WL; Petty WJ; Mehta K; Faller BA; et al. (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2025)